UY26649A1 - PROTEIN THAT HAS ANGIOGENESIS MODULATING ACTIVITY - Google Patents
PROTEIN THAT HAS ANGIOGENESIS MODULATING ACTIVITYInfo
- Publication number
- UY26649A1 UY26649A1 UY26649A UY26649A UY26649A1 UY 26649 A1 UY26649 A1 UY 26649A1 UY 26649 A UY26649 A UY 26649A UY 26649 A UY26649 A UY 26649A UY 26649 A1 UY26649 A1 UY 26649A1
- Authority
- UY
- Uruguay
- Prior art keywords
- protein
- angiogenesis
- modulating activity
- diseases
- angiogenesis modulating
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La BTL-012 es una nueva proteína humana útil para regular o modular la angiogénesis. La BTL-012, o sus variantes, pueden emplearse como terapia en enfermedades como el cáncer, la curación de heridas, las retinopatías diabéticas, la degeneración macular, y las enfermedades cardiovasculares y otras enfermedades o condiciones clínicas en las cuales la angiogénesis es relevante a la causa o el tratamiento de la enfermedad.BTL-012 is a new human protein useful for regulating or modulating angiogenesis. BTL-012, or its variants, can be used as therapy in diseases such as cancer, wound healing, diabetic retinopathies, macular degeneration, and cardiovascular diseases and other diseases or clinical conditions in which angiogenesis is relevant to the cause or treatment of the disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54080500A | 2000-03-31 | 2000-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26649A1 true UY26649A1 (en) | 2001-10-25 |
Family
ID=37515409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26649A UY26649A1 (en) | 2000-03-31 | 2001-04-02 | PROTEIN THAT HAS ANGIOGENESIS MODULATING ACTIVITY |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR027764A1 (en) |
| CO (1) | CO5280064A1 (en) |
| DO (1) | DOP2001000141A (en) |
| GT (1) | GT200100051A (en) |
| UY (1) | UY26649A1 (en) |
-
2001
- 2001-03-30 DO DO2001000141A patent/DOP2001000141A/en unknown
- 2001-03-30 CO CO01025571A patent/CO5280064A1/en not_active Application Discontinuation
- 2001-03-30 GT GT200100051A patent/GT200100051A/en unknown
- 2001-04-02 UY UY26649A patent/UY26649A1/en unknown
- 2001-04-03 AR ARP010101581A patent/AR027764A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200100051A (en) | 2002-04-23 |
| DOP2001000141A (en) | 2002-02-28 |
| AR027764A1 (en) | 2003-04-09 |
| CO5280064A1 (en) | 2003-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE486860T1 (en) | PHENOTHIAZINE DERIVATIVE FOR WOUND HEALING | |
| ATE339187T1 (en) | USE OF COMPOSITIONS CONTAINING ANTISEPTICS AND/OR WOUND HEALING PROMOTING ACTIVES FOR THE DEEP RESPIRATORY TRACT | |
| ES2077530A1 (en) | Pharmaceutical products for curing tumorous diseases and process for preparing same | |
| ATE415962T1 (en) | USE OF ASIATIC ACID OR ASIATICOSIDE TO TREAT CANCER | |
| UY28396A1 (en) | VEGF TRUMPS AND THERAPEUTIC USES OF THE SAME | |
| ATE361084T1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING PROANTHOCYANIDINS, GLYCYRRHETINIC ACID AND TELMESTEINS FOR THE TREATMENT OF DERMATITIS | |
| ES2157422T3 (en) | TRIGLICERIDS AND ETHYL ESTERS OF PHENYLALCANOIC ACID AND PHENYLALKYEN ACID USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS. | |
| MX9501848A (en) | New polyenic compounds, pharmaceutical and cosmetic compositions containing them and their uses. | |
| BR9806705A (en) | Skin rejuvenation recovery system. | |
| ATE332136T1 (en) | AGENTS SUCH AS NICOTINAMIDE OR CADPR FOR THE TREATMENT OF SKIN DISEASES | |
| AR046993A1 (en) | QUINAZOLINE DERIVATIVES | |
| BRPI0418157A (en) | allogeneic tumor therapy | |
| NO20050063L (en) | 2-heteroaryl carboxamides | |
| CY1111353T1 (en) | USE OF KALALIDIS COMPOUNDS FOR PRODUCTION OF MEDICINE FOR TREATMENT OF PORCELAIN | |
| ES2186576A1 (en) | 2-HYDROXYOLEIC ACID TO USE AS A MEDICINAL PRODUCT. | |
| DK1343472T3 (en) | Thixotropic nasal spray | |
| UY26649A1 (en) | PROTEIN THAT HAS ANGIOGENESIS MODULATING ACTIVITY | |
| Shah et al. | Trichofolliculoma–'troll hair'dermoscopy. | |
| ATE252383T1 (en) | USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND/OR ITS PHYSIOLOGICALLY TOLERABLE SALTS FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF CANCER DISEASES | |
| DOP2001000164A (en) | METHOD FOR REGULATING ANGIOGENESIS USING RYK PROTEIN | |
| ES2110057T3 (en) | MEDICINAL COMPOSITION CONTAINING TCF-II. | |
| DE602005020178D1 (en) | 5,6,7-TRIHYDROXYPHEPTANIC ACIDS AND ANALOGS FOR THE TREATMENT OF EYE DISEASES AND DISEASES ASSOCIATED WITH HYPERPROLIFERATIVES AND ANGIOGENIC REACTIONS | |
| ES2192810T3 (en) | EMPLOYMENT OF MONOXIDINE AS A MEDICINAL FOR STIMULATING ACTIVITY OF THERMOGENESIS. | |
| SV2002000362A (en) | PROTEINS THAT HAVE AN ANGIOGENESIS MODULATING ACTIVITY REF.MSB-7265-SV | |
| ATE239492T1 (en) | USE OF A BPI PROTEIN TO PRODUCE A MEDICATION FOR THE TREATMENT OF CHRONIC HEART DISEASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DESI | Application deemed to be withdrawn |
Effective date: 20111129 |